WithdrawnNot applicableNCT01660347
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Studying Acquired neutropenia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Principal Investigator
- Dolores Grosso, DNP, CRNPThomas Jefferson University
- Intervention
- Allogeneic hematopoietic stem cell transplantation(biological)
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2014
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01660347 on ClinicalTrials.govOther trials for Acquired neutropenia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsX4 Pharmaceuticals
- RECRUITINGPHASE1, PHASE2NCT00967785A Phase I Study of Mozobil in the Treatment of Patients With WHIMSNational Institute of Allergy and Infectious Diseases (NIAID)